The other SubB2M test is an SPR technology (surface plasma resonance). We need the data from the SubB2M ELISA test to be certain the same performance can be achieved. No point chucking out any technologies just yet from what i understand.
Ann: BARD1 Collaborator Uni of QLD Announces Ovarian Cancer Data, page-15
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
46.5¢ |
Change
-0.015(3.13%) |
Mkt cap ! $51.85M | |||
| Open | High | Low | Value | Volume |
| 48.0¢ | 48.0¢ | 46.0¢ | $95.71K | 205.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | 46.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 48.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 15.20pm 11/10/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |